天然产物研究与开发 ›› 2023, Vol. 35 ›› Issue (5): 901-913.doi: 10.16333/j.1001-6880.2023.5.018

• 综述 • 上一篇    

极地放线菌次级代谢产物及药理活性研究进展

代   影1,杨   帆2,林厚文2*   

  1. 1上海海洋大学食品学院,上海 201306;2上海交通大学医学院附属仁济医院药学部,上海 200127
  • 出版日期:2023-05-26 发布日期:2023-05-26
  • 基金资助:
    国家自然科学基金联合基金(U2106227)

Research progress on secondary metabolites and pharmacological activities of polar actinomycetes

DAI Ying1,YANG Fan2,LIN Hou-wen2 *   

  1. 1College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China;2Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
  • Online:2023-05-26 Published:2023-05-26

摘要: 极地微生物处在南北极严峻、极端的自然环境下,体内的一些“沉默基因”可能会被激活,形成了独特的生存机制和生物合成途径,能够产生化学结构多样、活性显著的次级代谢产物。近年来,从极地放线菌中分离鉴定出一系列结构新颖、活性突出的次级代谢产物。本文综述了1999至2021年间的极地放线菌次级代谢产物及药理活性的研究进展,将极地放线菌来源的104个次级代谢产物按肽类、生物碱类、萜类、大环内酯类、聚酮类、大环内酰胺类等化学类别,着重介绍结构新颖和活性突出的次级代谢产物,为进一步开发利用极地放线菌、研发创新药物提供参考。

关键词: 极地, 放线菌, 次级代谢产物, 生物活性

Abstract:

Polar microorganisms inhabits a harsh and extreme natural environment in polar region.Some “silent genes” inherited by polar microorganisms might be activated by extreme environment to form unique survival metabolism and biosynthetic pathway.In this context,a series of secondary metabolites with novel structure and prominent bioactivity have been found from polar actinomycetes.Here present a research progress on secondary metabolites and related pharmacological activities of polar actinomycetes from 1999 to 2021.A total of 104 secondary metabolites from polar actinomycetes were classified into peptides,alkaloids,terpenoids,macrolides,polyketides,macrolactams and miscellaneous according to chemical structures.The secondary metabolites with novel structures and attractive bioactivities were emphasized to provide reference for future development and utilization of polar actinomycetes.

Key words: polar regions, actinomycetes, secondary metabolites, bioactivities

中图分类号:  R931